What are the major opportunities in the Primary Immunodeficiency Disorders market? What are the strategies for the Primary Immunodeficiency Disorders market?

For detailed insights on the major opportunities and strategies in the Primary Immunodeficiency Disorders market, Read More

How does the Primary Immunodeficiency Disorders market relate to the overall economy and other similar markets?

For detailed insights on Primary Immunodeficiency Disorders's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Primary Immunodeficiency Disorders market growth? SWOT analysis of the Primary Immunodeficiency Disorders market.

For detailed insights on the key dynamics influencing the Primary Immunodeficiency Disorders market growth and SWOT analysis of the Primary Immunodeficiency Disorders industry, Read More

Global Primary Immunodeficiency Disorders Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Primary Immunodeficiency Disorders Global Market Report 2025

Name: Primary Immunodeficiency Disorders Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases ), By Treatment (Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments), By Diagnostic Type (Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types), By End-User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutions) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Primary Immunodeficiency Disorders Market Overview

• Primary Immunodeficiency Disorders market size has reached to $6.84 billion in 2024

• Expected to grow to $9.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Increasing Prevalence Of Autoimmune Diseases Driving Growth Of The Market Due To Rising Cases Of Immune System Dysfunction

• Market Trend: Innovative Developments In Intravenous Immunoglobulin (IVIG) Therapy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Primary Immunodeficiency Disorders Market?

Primary immunodeficiency disorders (PIDs) are inherited conditions that weaken or impair the immune system, increasing vulnerability to infections, autoimmune diseases, and certain cancers. Identifying and diagnosing primary immunodeficiency disorders early is crucial for timely treatment, infection prevention, and enhancing patient well-being through therapies such as immunoglobulin replacement or bone marrow transplants.

The main diseases in primary immunodeficiency disorders are antibody deficiency, cellular immunodeficiency, innate immune disorders, and others. Antibody deficiencies arise when the immune system fails to produce adequate antibodies, which are proteins responsible for identifying and neutralizing harmful pathogens. Available treatments include immunoglobulin replacement therapy, antibiotic therapy, stem cell and bone marrow transplantation, gene therapy, and others. Diagnostic methods encompass genetic testing, blood testing, flow cytometry, and others and are utilized in hospitals, specialty clinics, homecare settings, and research institutions.

Primary Immunodeficiency Disorders Market Size and growth rate 2025 to 2029: Graph

What Is The Primary Immunodeficiency Disorders Market Size 2025 And Growth Rate?

What Is The Primary Immunodeficiency Disorders Market Growth Forecast?

The primary immunodeficiency disorders market size is expected to see strong growth in the next few years. It will grow to $9.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing adoption of subcutaneous therapies, improving healthcare access, robust research and development, increasing high need for efficient treatments, and rising demand for immunoglobulin replacement therapy. Major trends in the forecast period include advancement in biotechnology, Innovative gene therapies and biologics, advancements in genetic testing and personalized medicine, advancements in gene therapy, and advancements in genetic tests.

The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of immunoglobulin therapies and genetic testing kits sourced from Switzerland and Ireland, thereby delaying diagnoses and elevating immunology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Primary Immunodeficiency Disorders Market Segmented?

1) By Disease: Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases

2) By Treatment: Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments

3) By Diagnostic Type: Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types

4) By End-User: Hospitals, Specialty Clinics, Homecare Settings, Research Institutions

Subsegments:

1) By Antibody Deficiency: Common Variable Immune Deficiency (CVID), IgA Deficiency, IgG Subclass Deficiency, Specific Antibody Deficiency

2) By Cellular Immunodeficiency: Severe Combined Immunodeficiency (SCID), T-Cell Deficiency, DiGeorge Syndrome, Wiskott-Aldrich Syndrome

3) By Innate Immune Disorders: Chronic Granulomatous Disease (CGD), Complement Deficiencies, Toll-like Receptor Deficiencies, Chediak-Higashi Syndrome

4) By Other Diseases: Hyper IgM Syndrome, Hyper IgE Syndrome, Ataxia-Telangiectasia, Combined Immunodeficiencies With Syndromic Features

What Is Driving The Primary Immunodeficiency Disorders Market? Increasing Prevalence Of Autoimmune Diseases Driving Growth Of The Market Due To Rising Cases Of Immune System Dysfunction

The growing prevalence of autoimmune diseases is expected to propel the growth of the primary immunodeficiency disorders market going forward. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues, treating them as foreign threats. This abnormal response leads to inflammation and damage in various organs and systems. The rise in autoimmune diseases is attributed to a complex interplay of environmental triggers, genetic predispositions, and lifestyle changes. Autoimmune diseases can cause primary immunodeficiency disorders by disrupting immune regulation and targeting immune cells, leading to weakened or dysfunctional immune responses. For instance, in November 2024, according to the Versorgungsatlas.de, a Germany-based interactive online platform, in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Therefore, the growing prevalence of autoimmune diseases is driving the growth of the primary immunodeficiency disorders industry.

Who Are The Major Players In The Global Primary Immunodeficiency Disorders Market?

Major companies operating in the primary immunodeficiency disorders market are Pfizer Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceuticals, CSL Behring, Baxter International Inc., Grifols SA, Octapharma, Kedrion Biopharma, Miltenyi Biotec, LFB Group, Clinigen Limited, ADMA Biologics Inc., Bio Products Laboratory Ltd, BD Biosciences, Cellectis SA, Florencia Healthcare, X4 Pharmaceuticals Inc., Amber Lifesciences, bluebird bio Inc., Chengdu Rongsheng Pharmaceutical Co Ltd.

What Are The Key Trends Of The Global Primary Immunodeficiency Disorders Market? Innovative Developments In Intravenous Immunoglobulin (IVIG) Therapy

Major companies operating in the primary immunodeficiency disorders market are focusing on developing advanced therapies such as intravenous immunoglobulin therapy to enhance patient outcomes by improving immune function. Intravenous immunoglobulin (IVIG) therapy is a treatment in which immunoglobulin (antibodies) derived from donor plasma is administered directly into a patient's bloodstream via an IV. For instance, in June 2024, Grifols, a Spain-based healthcare company, received FDA approval for Yimmugo, an intravenous immunoglobulin (IVIg) therapy. This newly developed, sugar-free, ready-to-use IgG solution is derived from human blood plasma and is intended for intravenous administration. Approved in the U.S. for substitution therapy in patients with primary antibody deficiency syndromes, Yimmugo provides antibody replacement to support individuals with immune system deficiencies. It enhances Grifols’ portfolio of plasma-based treatments by offering a safer and more effective option to help protect against infections.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Primary Immunodeficiency Disorders Market? Grifols Acquires Biotest AG To Expand Plasma-Derived Medicines Portfolio

In April 2022, Grifols, S.A., a Spain-based pharmaceutical company, acquired Biotest AG for an undisclosed amount. The acquisition aims to accelerate growth and innovation by expanding its plasma-derived medicines portfolio and strengthening its global market presence. Biotest AG is a Germany-based biotechnology company that specializes in plasma proteins and biological drugs.

What Is The Regional Outlook For The Global Primary Immunodeficiency Disorders Market?

North America was the largest region in the primary immunodeficiency disorders market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Primary Immunodeficiency Disorders Market?

The primary immunodeficiency disorders market consists of revenues earned by entities by providing services such as immunoglobulin therapy, rehabilitation and support programs, educational and advocacy services, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary immunodeficiency disorders market also includes sales of vaccines, antibiotics, antifungals, and small molecule drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Primary Immunodeficiency Disorders Industry?

The primary immunodeficiency disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the primary immunodeficiency disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Primary Immunodeficiency Disorders Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.3 billion
Revenue Forecast In 2034	$9.43 billion
Growth Rate	CAGR of 6.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The primary immunodeficiency disorders market covered in this report is segmented – 1) By Disease: Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Other Diseases 2) By Treatment: Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell And Bone Marrow Transplantation, Gene Therapy, Other Treatments 3) By Diagnostic Type: Genetic Testing, Blood Testing, Flow Cytometry, Other Diagnostic Types 4) By End-User: Hospitals, Specialty Clinics, Homecare Settings, Research Institutions Subsegments: 1) By Antibody Deficiency: Common Variable Immune Deficiency (CVID), IgA Deficiency, IgG Subclass Deficiency, Specific Antibody Deficiency 2) By Cellular Immunodeficiency: Severe Combined Immunodeficiency (SCID), T-Cell Deficiency, DiGeorge Syndrome, Wiskott-Aldrich Syndrome 3) By Innate Immune Disorders: Chronic Granulomatous Disease (CGD), Complement Deficiencies, Toll-like Receptor Deficiencies, Chediak-Higashi Syndrome 4) By Other Diseases: Hyper IgM Syndrome, Hyper IgE Syndrome, Ataxia-Telangiectasia, Combined Immunodeficiencies With Syndromic Features
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Primary Immunodeficiency Disorders Market Characteristics

3. Primary Immunodeficiency Disorders Market Trends And Strategies

4. Primary Immunodeficiency Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Primary Immunodeficiency Disorders Growth Analysis And Strategic Analysis Framework

5.1. Global Primary Immunodeficiency Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Primary Immunodeficiency Disorders Market Growth Rate Analysis

5.4. Global Primary Immunodeficiency Disorders Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Primary Immunodeficiency Disorders Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Primary Immunodeficiency Disorders Total Addressable Market (TAM)

6. Primary Immunodeficiency Disorders Market Segmentation

6.1. Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antibody Deficiency

Cellular Immunodeficiency

Innate Immune Disorders

Other Diseases

6.2. Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunoglobulin Replacement Therapy

Antibiotic Therapy

Stem Cell And Bone Marrow Transplantation

Gene Therapy

Other Treatments

6.3. Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Testing

Blood Testing

Flow Cytometry

Other Diagnostic Types

6.4. Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Homecare Settings

Research Institutions

6.5. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Common Variable Immune Deficiency (CVID)

IgA Deficiency

IgG Subclass Deficiency

Specific Antibody Deficiency

6.6. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Severe Combined Immunodeficiency (SCID)

T-Cell Deficiency

DiGeorge Syndrome

Wiskott-Aldrich Syndrome

6.7. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Granulomatous Disease (CGD)

Complement Deficiencies

Toll-like Receptor Deficiencies

Chediak-Higashi Syndrome

6.8. Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hyper IgM Syndrome

Hyper IgE Syndrome

Ataxia-Telangiectasia

Combined Immunodeficiencies With Syndromic Features

7. Primary Immunodeficiency Disorders Market Regional And Country Analysis

7.1. Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Primary Immunodeficiency Disorders Market

8.1. Asia-Pacific Primary Immunodeficiency Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Primary Immunodeficiency Disorders Market

9.1. China Primary Immunodeficiency Disorders Market Overview

9.2. China Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Primary Immunodeficiency Disorders Market

10.1. India Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Primary Immunodeficiency Disorders Market

11.1. Japan Primary Immunodeficiency Disorders Market Overview

11.2. Japan Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Primary Immunodeficiency Disorders Market

12.1. Australia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Primary Immunodeficiency Disorders Market

13.1. Indonesia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Primary Immunodeficiency Disorders Market

14.1. South Korea Primary Immunodeficiency Disorders Market Overview

14.2. South Korea Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Primary Immunodeficiency Disorders Market

15.1. Western Europe Primary Immunodeficiency Disorders Market Overview

15.2. Western Europe Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Primary Immunodeficiency Disorders Market

16.1. UK Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Primary Immunodeficiency Disorders Market

17.1. Germany Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Primary Immunodeficiency Disorders Market

18.1. France Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Primary Immunodeficiency Disorders Market

19.1. Italy Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Primary Immunodeficiency Disorders Market

20.1. Spain Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Primary Immunodeficiency Disorders Market

21.1. Eastern Europe Primary Immunodeficiency Disorders Market Overview

21.2. Eastern Europe Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Primary Immunodeficiency Disorders Market

22.1. Russia Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Primary Immunodeficiency Disorders Market

23.1. North America Primary Immunodeficiency Disorders Market Overview

23.2. North America Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Primary Immunodeficiency Disorders Market

24.1. USA Primary Immunodeficiency Disorders Market Overview

24.2. USA Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Primary Immunodeficiency Disorders Market

25.1. Canada Primary Immunodeficiency Disorders Market Overview

25.2. Canada Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Primary Immunodeficiency Disorders Market

26.1. South America Primary Immunodeficiency Disorders Market Overview

26.2. South America Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Primary Immunodeficiency Disorders Market

27.1. Brazil Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Primary Immunodeficiency Disorders Market

28.1. Middle East Primary Immunodeficiency Disorders Market Overview

28.2. Middle East Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Primary Immunodeficiency Disorders Market

29.1. Africa Primary Immunodeficiency Disorders Market Overview

29.2. Africa Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Primary Immunodeficiency Disorders Market Competitive Landscape And Company Profiles

30.1. Primary Immunodeficiency Disorders Market Competitive Landscape

30.2. Primary Immunodeficiency Disorders Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Takeda Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

30.2.4. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Primary Immunodeficiency Disorders Market Other Major And Innovative Companies

31.1. Grifols SA

31.2. Octapharma

31.3. Kedrion Biopharma

31.4. Miltenyi Biotec

31.5. LFB Group

31.6. Clinigen Limited

31.7. ADMA Biologics Inc.

31.8. Bio Products Laboratory Ltd

31.9. BD Biosciences

31.10. Cellectis SA

31.11. Florencia Healthcare

31.12. X4 Pharmaceuticals Inc.

31.13. Amber Lifesciences

31.14. bluebird bio Inc.

31.15. Chengdu Rongsheng Pharmaceutical Co Ltd

32. Global Primary Immunodeficiency Disorders Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Primary Immunodeficiency Disorders Market

34. Recent Developments In The Primary Immunodeficiency Disorders Market

35. Primary Immunodeficiency Disorders Market High Potential Countries, Segments and Strategies

35.1 Primary Immunodeficiency Disorders Market In 2029 - Countries Offering Most New Opportunities

35.2 Primary Immunodeficiency Disorders Market In 2029 - Segments Offering Most New Opportunities

35.3 Primary Immunodeficiency Disorders Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Thermo Fisher Scientific Inc. Financial Performance

Table 81: Takeda Pharmaceuticals Financial Performance

Table 82: CSL Behring Financial Performance

Table 83: Baxter International Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Primary Immunodeficiency Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Antibody Deficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Cellular Immunodeficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Innate Immune Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Primary Immunodeficiency Disorders Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Primary Immunodeficiency Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Primary Immunodeficiency Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Primary Immunodeficiency Disorders Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Thermo Fisher Scientific Inc. Financial Performance

Figure 81: Takeda Pharmaceuticals Financial Performance

Figure 82: CSL Behring Financial Performance

Figure 83: Baxter International Inc. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Immunoassay Global Market Report 2025 – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Monitoring, O...

Acne Drugs Global Market Report 2025 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hos...

Immunodiagnostics Global Market Report 2025 – By Product (Reagents And Consumables, Instruments, Software And Services ), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immun...

Syphilis Immunoassay Diagnostics Global Market Report 2025 – By Product (Analyzers, Reagents, Kits, Other Products), By Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other T...

Walking Aids Global Market Report 2025 – By Product Type (Crutches, Canes, Walkers, Rollators, Other Products), By Technology (Automated, Manual), By End-User (Hospitals And Clinics, Home Care Settings, Other End Users) ...

Emphysema Global Market Report 2025 – By Type (Centrilobular, Panlobular), By Treatment (Medication, Therapy, Surgery, Other Treatments), By Diagnosis (Imaging Test, Lung Function Test, Other Diagnosis), By Complications...

Immunohematology Global Market Report 2025 – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)), By Di...

Frequently Asked Questions

What is the definition of the Primary Immunodeficiency Disorders market?

How will the Primary Immunodeficiency Disorders market drivers and restraints affect the market dynamics? What forces will shape the Primary Immunodeficiency Disorders industry going forward?

The market major growth driver - Increasing Prevalence Of Autoimmune Diseases Driving Growth Of The Market Due To Rising Cases Of Immune System Dysfunction. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Primary Immunodeficiency Disorders market?

The primary immunodeficiency disorders market size has grown strongly in recent years. It will grow from $6.84 billion in 2024 to $7.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising incidence of primary immunodeficiency disorders, increasing awareness among healthcare professionals, increasing demand for effective treatment, increasing research funding, and growing focus on pediatric care. The primary immunodeficiency disorders market size is expected to see strong growth in the next few years. It will grow to " $9.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing adoption of subcutaneous therapies, improving healthcare access, robust research and development, increasing high need for efficient treatments, and rising demand for immunoglobulin replacement therapy. Major trends in the forecast period include advancement in biotechnology, Innovative gene therapies and biologics, advancements in genetic testing and personalized medicine, advancements in gene therapy, and advancements in genetic tests. For further insights on this market, request a sample here

How is the Primary Immunodeficiency Disorders market segmented?

The primary immunodeficiency disordersmarket covered in this report is segmented –
1) By Disease: Antibody Deficiency; Cellular Immunodeficiency; Innate Immune Disorders; Other Diseases
2) By Treatment: Immunoglobulin Replacement Therapy; Antibiotic Therapy; Stem Cell And Bone Marrow Transplantation; Gene Therapy; Other Treatments
3) By Diagnostic Type: Genetic Testing; Blood Testing; Flow Cytometry; Other Diagnostic Types
4) By End-User: Hospitals; Specialty Clinics; Homecare Settings; Research Institutions Subsegments:
1) By Antibody Deficiency: Common Variable Immune Deficiency (CVID); IgA Deficiency; IgG Subclass Deficiency; Specific Antibody Deficiency
2) By Cellular Immunodeficiency: Severe Combined Immunodeficiency (SCID); T-Cell Deficiency; DiGeorge Syndrome; Wiskott-Aldrich Syndrome
3) By Innate Immune Disorders: Chronic Granulomatous Disease (CGD); Complement Deficiencies; Toll-like Receptor Deficiencies; Chediak-Higashi Syndrome
4) By Other Diseases: Hyper IgM Syndrome; Hyper IgE Syndrome; Ataxia-Telangiectasia; Combined Immunodeficiencies With Syndromic Features For further insights on this market, request a sample here

Which region has the largest share of the Primary Immunodeficiency Disorders market? What are the other regions covered in the report?

North America was the largest region in the primary immunodeficiency disorders market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary immunodeficiency disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Primary Immunodeficiency Disorders market?

What are the key trends in the Primary Immunodeficiency Disorders market?

Major trends in this market include Innovative Developments In Intravenous Immunoglobulin (IVIG) Therapy. For further insights on this market, request a sample here.